These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15077130)

  • 21. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study.
    Benito AI; Gonzalez-Vicent M; Garcia F; Balas A; Quintero V; Madero L; Vicario JL; Diaz MA
    Bone Marrow Transplant; 2001 Sep; 28(6):537-43. PubMed ID: 11607765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.
    Teltschik HM; Heinzelmann F; Gruhn B; Feuchtinger T; Schlegel P; Schumm M; Kremens B; Müller I; Ebinger M; Schwarze CP; Ottinger H; Zips D; Handgretinger R; Lang P
    Br J Haematol; 2016 Oct; 175(1):115-22. PubMed ID: 27341180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
    Hubmann M; Fritsch S; Zoellner AK; Prevalsek D; Engel N; Bücklein V; Mumm F; Schulz C; Stemmler HJ; Jäger G; Ledderose G; Kolb HJ; Hausmann A; Hiddemann W; Moosmann A; Tischer J
    J Clin Virol; 2016 Sep; 82():33-40. PubMed ID: 27428881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.
    Goto H; Kaneko T; Shioda Y; Kajiwara M; Sakashita K; Kitoh T; Hayakawa A; Miki M; Kato K; Ogawa A; Hashii Y; Inukai T; Kato C; Sakamaki H; Yabe H; Suzuki R; Kato K
    Pediatr Blood Cancer; 2015 Jan; 62(1):148-52. PubMed ID: 25262825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
    Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
    JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
    Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
    Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria.
    Benakli M; Ahmed Nacer R; Mehdid F; Belhadj R; Talbi A; Rahmoune N; Niederwieser C; Baazizi M; Akhrouf S; Ait Ouali D; Bouarab H; Zerkout S; Abderahim I; Harieche F; Hamladji RM
    Ann Hematol; 2020 Mar; 99(3):619-625. PubMed ID: 31974679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children.
    Zama D; Masetti R; Cordelli DM; Vendemini F; Giordano L; Milito G; Franzoni E; Porta F; Prete A; Rondelli R; Pession A
    Bone Marrow Transplant; 2014 Dec; 49(12):1538-40. PubMed ID: 25133894
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
    Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
    Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
    Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
    Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit.
    An K; Wang Y; Li B; Luo C; Wang J; Luo C; Chen J
    BMC Pediatr; 2016 Aug; 16(1):138. PubMed ID: 27544347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early bacterial and fungal infection in children receiving allogeneic stem cell transplantation for acute lymphoblastic leukemia in Argentina.
    Gomez S; Fynn AB; Fernanda S; Cecilia V; Sung L
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29082673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of late onset non-infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation.
    Park M; Koh KN; Kim BE; Im HJ; Seo JJ
    Clin Transplant; 2011; 25(2):E168-76. PubMed ID: 21077955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center.
    Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH
    J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiology, characteristics and outcome of seizures after pediatric hematopoietic stem cell transplantation.
    Cordelli DM; Masetti R; Zama D; Gueraldi D; Rondelli R; Cottone C; Prete A; Pession A; Franzoni E
    Seizure; 2014 Feb; 23(2):140-5. PubMed ID: 24287078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic efficacy of allogeneic hematopoietic stem cell transplantation in children with chronic myelogenous leukemia].
    Jiang H; Hu WT; Chen J; Luo CY; Wang JM; Zhou M; Ye QD; Tang YJ; Luo CJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jan; 15(1):19-24. PubMed ID: 23336162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Qin YZ; Chen Y; Xu LP; Wang Y; Zhang XH; Chen H; Zhao XS; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):163-168. PubMed ID: 28939454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donors.
    Mussetti A; Kernan NA; Prockop SE; Scaradavou A; Lehrman R; Ruggiero JM; Curran K; Kobos R; O'Reilly R; Boulad F
    Pediatr Hematol Oncol; 2016 Sep; 33(6):347-358. PubMed ID: 27715384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.